Pharmaceutical Technology's In the Lab eNewsletter, March 2023

March 01, 2023

Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.

March 01, 2023

The further we pursue CGT, the more variability we need to account for in order to engineer consistency into these new products.

February 27, 2023

Bio-Rad’s newly launched StarBright Blue and StarBright Yellow dyes are intended for use in various flow cytometry applications.

February 27, 2023

Eurofins Viracor ExPeCT CAR-T qPCR assay is a tool designed for monitoring and optimizating CAR-T therapies.

February 24, 2023

Moderna will leverage Life Edit’s suite of gene editing technologies to advance development of in vivo gene editing therapies.

February 24, 2023

AbbVie and Capsida have expanded their existing collaboration to advance three new gene therapy programs.

February 24, 2023

The goal of this collaboration is to develop an approach to personalized radiotherapy and drug discovery that is based in genomics and artificial intelligence.

February 22, 2023

Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.

February 15, 2023

The kit is meant for use for the detection and quantitation of residual host cell protein.

February 07, 2023

Thermo Fisher and Celltrio are introducing a new automation platform to address critical scale-up challenges in biotherapeutics.

February 07, 2023

iotaSciences isoPick is designed to expand handling solutions for cell biology and gene therapy applications.

February 06, 2023

Thermo Fisher’s sponsorship of Momentum Labs is intended to support biotech businesses in the greater Gainesville region.